{"data":[{"accessionNo":"0000935836-26-000442","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":"00791X209","securityClass":"Class A Common Stock","eventDate":"2026-08-19","reportingPerson":"Timothy P. Lynch","reportingCik":null,"personType":"IN","sharesOwned":6500000,"percentOfClass":13,"filedAt":"2026-08-21","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001440771-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":"00791X209","securityClass":"Class A Common Stock","eventDate":"2026-07-15","reportingPerson":"Stonepine Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":6892682,"percentOfClass":9.9,"filedAt":"2026-07-21","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001440771-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":"00791X209","securityClass":"Class A Common Stock","eventDate":"2026-07-15","reportingPerson":"Stonepine Capital, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6892682,"percentOfClass":9.9,"filedAt":"2026-07-21","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001440771-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":"00791X209","securityClass":"Class A Common Stock","eventDate":"2026-07-15","reportingPerson":"Stonepine GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":6892682,"percentOfClass":9.9,"filedAt":"2026-07-21","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001440771-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":"00791X209","securityClass":"Class A Common Stock","eventDate":"2026-07-15","reportingPerson":"Jon M. Plexico","reportingCik":null,"personType":"HC,IN","sharesOwned":6892682,"percentOfClass":9.9,"filedAt":"2026-07-21","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001213900-26-009802","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-01-21","reportingPerson":"Daewoong Co.,Ltd. (\"DWC\")","reportingCik":"0001985493","personType":"CO","sharesOwned":12009737,"percentOfClass":49.99,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001213900-26-009802","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-01-21","reportingPerson":"Daewoong Pharmaceutical Co. Ltd (\"DWP\")","reportingCik":null,"personType":"CO","sharesOwned":12009737,"percentOfClass":49.75,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001213900-26-009785","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-03-24","reportingPerson":"Daewoong Co.,Ltd. (\"DWC\")","reportingCik":"0001985493","personType":"CO","sharesOwned":91357,"percentOfClass":0.9,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001213900-26-009785","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-03-24","reportingPerson":"Daewoong Pharmaceutical Co. Ltd (\"DWP\")","reportingCik":null,"personType":"CO","sharesOwned":33334,"percentOfClass":0.3,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"},{"accessionNo":"0001896206-25-000007","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001837607","issuerName":"AEON Biopharma, Inc.","ticker":"AEON","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Alta Partners LLC","reportingCik":null,"personType":"OO","sharesOwned":249870,"percentOfClass":2.1,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/aeon"}],"updatedAt":"2026-11-04T03:22:22.015Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/aeon","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}